Corbus Pharmaceuticals Holdings, Inc.
CRBPNasdaqCIK 1595097HealthcareFiscal year ends Dec 31
Reports and events: 250 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1510:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422437 |
| 2026-09-1407:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389829 |
| 2026-08-0616:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338274 |
| 2026-08-0608:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-336864 |
| 2026-07-0608:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-295622 |
| 2026-05-2608:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-238059 |
| 2026-05-2108:15 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-233507 |
| 2026-05-1408:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-222890 |
| 2026-05-1216:50 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219707 |
| 2026-05-1208:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-218250 |
| 2026-04-1616:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-159062 |
| 2026-04-1408:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-153923 |
| 2026-04-0708:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-144588 |
| 2026-04-0216:47 ET | DEF 14A | Proxy statementPeriod 2026-04-01 | 0001193125-26-140363 |
| 2026-03-0916:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-098530 |
| 2026-03-0907:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097582 |
| 2026-02-2507:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-068566 |
| 2026-01-1207:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009758 |
| 2025-12-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-324796 |
| 2025-12-1107:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-315039 |
| 2025-11-1216:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277748 |
| 2025-11-1208:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-276062 |
| 2025-11-0308:02 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-261722 |
| 2025-10-3016:34 ET | 8-K | 8.01 Other events | 0001193125-25-258692 |
| 2025-10-2007:53 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-243046 |
| 2025-09-1608:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-204389 |
| 2025-08-0516:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103118 |
| 2025-08-0509:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-102447 |
| 2025-05-1908:30 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-25-073967 |
| 2025-05-0616:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064507 |
| 2025-05-0608:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-063990 |
| 2025-04-0116:35 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0000950170-25-048603 |
| 2025-03-2116:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-043276 |
| 2025-03-1816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-041254 |
| 2025-03-1117:24 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-037335 |
| 2025-03-1108:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-036838 |
| 2025-02-1408:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-020424 |
| 2024-12-0308:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-132458 |
| 2024-11-1516:36 ET | 8-K | 8.01 Other events | 0000950170-24-127644 |
| 2024-11-0716:58 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123486 |
| 2024-11-0708:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122839 |
| 2024-11-0407:51 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-120289 |
| 2024-09-0316:52 ET | 8-K | 8.01 Other events | 0000950170-24-102878 |
| 2024-08-2008:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-098861 |
| 2024-08-0616:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-091931 |
| 2024-08-0616:38 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091922 |
| 2024-08-0608:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-091219 |
| 2024-06-1709:21 ET | 8-K | 8.01 Other events | 0000950170-24-074032 |
| 2024-06-0307:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-067651 |
| 2024-05-2016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-062436 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 11:04 ET. Listed shows no prices and gives no investment advice.